Diabetes Linked to Increased CVD, Cancer, Other Mortality

Share this content:
Diabetes Linked to Increased CVD, Cancer, Other Mortality
Diabetes Linked to Increased CVD, Cancer, Other Mortality

THURSDAY, Aug. 18, 2016 (HealthDay News) -- Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes, according to a study published online Aug. 4 in Diabetes Care.

Jose Miguel Baena-Díez, from the Hospital del Mar Research Institute in Barcelona, Spain, and colleagues used the pooled analysis of individual data from 12 Spanish cohorts with 10 years of follow-up to examine the correlation between diabetes and cause-specific death. Data were included for 55,292 individuals aged 35 to 79 years who had no previous history of cardiovascular diseases. The hazard ratios were assessed with and without competing risks: proportional subdistribution hazard (PSH) and cause-specific hazard (CSH), respectively.

The researchers found that 15.6 percent of participants had diabetes and that overall mortality was 9.1 percent. Diabetes increased mortality risk for cardiovascular death: CSH, 2.03 and PSH, 1.99 in men and CSH, 2.28 and PSH, 2.23 in women; cancer death: CSH, 1.37 and PSH, 1.35 for men and CSH, 1.68 and PSH, 1.66 in women; and noncardiovascular noncancer death: CSH, 1.53 and PSH, 1.5 in men and CSH, 1.89 and PSH, 1.84 in women. Individuals with diabetes had higher cumulative mortality function in all instances.

"Diabetes is associated with premature death from cardiovascular disease, cancer, and noncardiovascular noncancer causes," the authors write. "The use of CSH and PSH provides a comprehensive view of mortality dynamics in a population with diabetes."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Belimumab Aids Anti-dsDNA, Hypocomplementemic Lupus

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group

Too Few Adults Taking Epilepsy Meds Have Seizure Control

Too Few Adults Taking Epilepsy Meds Have Seizure ...

Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control

Pediatric Exposures to Liquid Nicotine Down From 2015 to 2016

Pediatric Exposures to Liquid Nicotine Down From 2015 ...

Still poses serious risk to children; decrease likely in part to law requiring child-resistant packaging

is free, fast, and customized just for you!

Already a member?

Sign In Now »